Elevating Medical Affairs: Impact Assessment & Value Communication

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Quantifying Impact & Telling the Value Story in Medical Affairs: Field Medical, Medical Education, Medical Operations & Medical Information”

STUDY OVERVIEW

In recent years, there has been a significant increase in Medical Affairs’ roles and responsibilities. However, many Medical leaders often struggle in quantifying the precise external impact of their function to effectively communicate their “value story” to the organization.

Best Practices LLC conducted extensive benchmarking research to examine how Medical Affairs groups assess the impact and value of each function including Field Medical, Medical Education, Medical Operations, and Medical Information groups. This research evaluates how the use of external metrics and value-based assessments transforms Medical Affairs functions and creates an engaging narrative for top-level management.

KEY TOPICS

Assessing Medical Affairs Impact & Value of Each Function

Field Medical
Medical Education
Medical Operations
Medical Information & Communications

Value Metrics
Impact Metrics
Driving External Impact

KEY METRICS

How valuable are each of the listed Field Medical, Medical Education, Medical Operations, and Medical Information & Communications activities to the organization?
How valuable are the listed KPIs to demonstrate the impact of activities among external stakeholders?
How successful have the Field Medical, Medical Education, Medical Operations, and Medical Information & Communications groups been in generating measurable, external impact across each of the listed external stakeholder objectives?

SAMPLE KEY FINDINGS

Medical Education Value Metrics: Developing new content (63% rated it highly valuable) and hosting webinar events (50% rated it highly valuable) are most effectively translated into measures of Medical Education value.

METHODOLOGY

Best Practices LLC engaged 38 Medical Affairs leaders from 31 leading pharmaceutical companies in this research through a benchmarking survey instrument. Deep-dive interviews were also conducted with Medical Affairs leaders at 10 organizations to capture additional insights.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Chemical; Clinical Research; Laboratories

Companies Profiled:
Abbott; Adaptimmune; ASC Therapeutics; Astellas; AstraZeneca; Baxter International; Bayer; bioMerieux; Boehringer Ingelheim; Domp�; Dermavant Sciences; Eisai; Eli Lilly; Genentech; GlaxoSmithKline ; GRAIL; Grifols; Jazz Pharmaceuticals; Merck; Myovant Sciences; Novartis; Novo Nordisk; OTSUKA; Pfizer; Roche; Sage Therapeutics; Sanofi; Santen; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Quantifying Impact & Telling the Value Story in Medical Affairs: Field Medical, Medical Education, Medical Operations & Medical Information

ID: 5765

Features:

Pages/Slides: 36

Published: 2023

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CBB868FBEB912D06002589EB004AF592
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-quantifying-impact-telling-value-story-in-medical-affairs-field-medical-education-operations-information?opendocument
18
19opendocument
2044.222.134.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB